Chimeric antigen receptors targeting g-protein coupled receptor and uses thereof
US-2024294599-A1 · Sep 5, 2024 · US
US2016376575A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016376575-A1 |
| Application number | US-201615194712-A |
| Country | US |
| Kind code | A1 |
| Filing date | Jun 28, 2016 |
| Priority date | Sep 30, 2011 |
| Publication date | Dec 29, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A peptide for synthesizing silica and use thereof are provided. The peptide for synthesizing silica can polymerize silica from a silica precursor in an aqueous solution having conditions of normal temperature, normal pressure and near-neutral weak base. The peptide for synthesizing silica can form a self-assembled structure during silica synthesis, and thus can be used as various biomaterials such as a silica-based protein immobilizer, a biosensor, and a drug delivery system.
Opening claim text (preview).
What is claimed is: 1 . A fusion protein comprising: at least one peptide selected from the group consisting of amino acid sequences set forth in SEQ ID NOs: 1 to 10; and a self-assembling protein. 2 . The fusion protein of claim 1 , wherein the self-assembling protein is a ferritin or a viral capsid protein. 3 . A composition for synthesizing silica, comprising the fusion protein of claim 1 . 4 . A silica complex in which surfaces of self-assembled structures of at least one peptide selected from the group consisting of amino acid sequences set forth in SEQ ID NOs: 1 to 10, and a self-assembling protein are coated with silica. 5 . A drug delivery system comprising: the silica complex of claim 4 ; and a pharmaceutically acceptable carrier. 6 . A contrast agent composition comprising: the silica complex of claim 4 ; and a pharmaceutically acceptable carrier. 7 . A target-directed contrast agent composition comprising: the silica complex of claim 4 ; and a pharmaceutically acceptable carrier. 8 . A contrast agent composition for simultaneous diagnosis or treatment, comprising: the silica complex of claim 4 ; and a pharmaceutically acceptable carrier. 9 . A multi-diagnostic probe comprising: the silica complex of claim 4 ; and a diagnostic probe. 10 . A fiber into which the silica complex of claim 4 is electrospun. 11 . A filter comprising the fiber into which the silica complex of claim 4 is electrospun. 12 . A bone substitute comprising the silica complex of claim 4 . 13 . A photonic device comprising the silica complex of claim 4 . 14 . A biosensor for detecting a biomolecule, comprising the silica complex of claim 4 . 15 . The biosensor of claim 14 , wherein the biomolecule is a nucleic acid, a protein, a polysaccharide, or a pathogen.
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof · CPC title
Phosphotransferases with an alcohol group as acceptor (2.7.1) · CPC title
Preparations for testing in vivo · CPC title
containing a domain for self-assembly, e.g. a viral coat protein (includes phage display) · CPC title
Peptides being immobilised on, or in, an inorganic carrier · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.